Skip to main content

Table 1 Demographic characteristics of the study participants

From: “SQiD, the Single Question in Delirium; can a single question help clinicians to detect delirium in hospitalised cancer patients?” running heading Single Question in Delirium” (Bcan-D-20-01665)

  Primary analysis N = 73 Secondary analysis N = 122
Gender   
 Male 33 (42%) 62 (51%)
 Female 39 (53%) 56 (46%)
Admitting team
 Medical Oncology 47 (64%) 85 (70%)
 Radiation Oncology 17 (23%) 22 (18%)
 Palliative Care 7 (10%) 9 (7%)
Admission indication
 Symptom management 55 (75%) 88 (72%)
Tumour type
 Lung 14 (19%) 23 (20%)
 Gastric and other upper GI 11 (15%) 15 (12%)
 Breast 10 (14%) 14 (11.5%)
 Prostate 3 (4%) 13 (11%)
 Colon 8 (11%) 9 (7%)
 Other 23 (31.5%) 39 (32%)
Tumour stage
 Stage I or II 8 (11%) 10 (8%)
 Stage III 12 (16%) 19 (15%)
 Stage IV 50 (68.5%) 85 (69.7%)
Site of metastasis
 No documented metastasis 20 (27%) 32 (26%)
 Bone 18 (25%) 24 (20%)
 Liver 10 (14%) 13 (11%)
 Lung 4 (5.5%) 7 (6%)
 Brain 3 (4%) 9 (7%)
 Multiple sites 12 (16%) 25 (20.5%)
 Unknown/missing 6 (8%) 10 (8%)
ECOG Score
 1 or less 22 (30%) 31 (25%)
 2 22 (30%) 40 (33%)
 3 or more 19 (26%) 34 (28%)
 Unknown/missing 10 (14%) 17 (14%)
SQiD informant cohabitation with patient 41 (56%) 69 (57%)
  Median (IQR) Median (IQR)
Age 68 (60.5–78) 68 (56–77.5)
Australia-Modified Karnofsky Score 70 (50–80) 70 (50–70)
  1. GI Gastro intestinal, IQR Interquartile range